-
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi-Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B. & Teunissen, C. E., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
-
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project
Collij, L. E., Salvadó, G., de Wilde, A., Altomare, D., Shekari, M., Gispert, J. D., Bullich, S., Stephens, A., Barkhof, F., Scheltens, P., Bouwman, F. & van der Flier, W. M., 1 Jun 2023, In: Alzheimer s & dementia. 19, 6, p. 2397-2407Research output: Contribution to journal › Article › Academic › peer-review
-
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting
van Maurik, I. S., Broulikova, H. M., Mank, A., Bakker, E. D., de Wilde, A., Bouwman, F. H., Stephens, A. W., van Berckel, B. N. M., Scheltens, P. & van der Flier, W. M., May 2023, In: Alzheimer's and Dementia. 19, 5, p. 2006-2013 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
